Millennium Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.69M | Sell |
1,512,058
-1,569,795
| -51% | -$10.1M | ﹤0.01% | 1632 |
|
|
2025
Q1 | $10.9M | Buy |
3,081,853
+2,487,617
| +419% | +$8.81M | 0.01% | 1454 |
|
|
2024
Q4 | $2.25M | Buy |
594,236
+137,420
| +30% | +$519K | ﹤0.01% | 2454 |
|
|
2024
Q3 | $1.48M | Sell |
456,816
-1,078,362
| -70% | -$3.49M | ﹤0.01% | 2724 |
|
|
2024
Q2 | $2.92M | Sell |
1,535,178
-936,277
| -38% | -$1.78M | ﹤0.01% | 2251 |
|
|
2024
Q1 | $7.02M | Buy |
2,471,455
+198,812
| +9% | +$565K | ﹤0.01% | 1738 |
|
|
2023
Q4 | $33.5M | Buy |
2,272,643
+153,108
| +7% | +$2.25M | 0.01% | 731 |
|
|
2023
Q3 | $38.8M | Buy |
2,119,535
+197,904
| +10% | +$3.62M | 0.02% | 577 |
|
|
2023
Q2 | $41.4M | Buy |
1,921,631
+847,021
| +79% | +$18.3M | 0.02% | 604 |
|
|
2023
Q1 | $31.5M | Buy |
1,074,610
+215,195
| +25% | +$6.31M | 0.02% | 695 |
|
|
2022
Q4 | $31.8M | Sell |
859,415
-61,713
| -7% | -$2.28M | 0.02% | 724 |
|
|
2022
Q3 | $25.9M | Buy |
921,128
+475,084
| +107% | +$13.4M | 0.02% | 736 |
|
|
2022
Q2 | $8.59M | Buy |
446,044
+308,803
| +225% | +$5.95M | 0.01% | 1680 |
|
|
2022
Q1 | $1.76M | Buy |
+137,241
| New | +$1.76M | ﹤0.01% | 3162 |
|